Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Rasagiline - Second-Generation MAO-B Inhibitor



Some examples of new approaches to the treatment of PD

Some examples of new approaches to the treatment of PD that are being developed.


Back to Project Details



Related Projects

Ariflo (Cilomilast) - Oral PDE-IV Inhibitor for
Ariflo (cilomilast) is an oral selective phosphodiesterase (PDE) IV...

Sativex - Investigational Cannabis-Based treatment for Pain and Multiple Sclerosis
Developed by GW Pharmaceuticals, Sativex is a whole plant medicinal...

Capravirine - Anti-Retroviral Drug
Developed by Pfizer Global Research and Development, capravirine is...

Acomplia (Rimonabant) - Investigational Agent for
Developed by Sanofi-Aventis, Acomplia (rimonabant) is a selective...

Tarceva - Small Molecule
Tarceva (erlotinib) is an oral anti-cancer drug developed by...

See all projects


Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2011 Net Resources International, a trading division of SPG Media Limited.